Aveanna Healthcare Holdings Inc. reported $2.60B of revenue over the trailing twelve months, +20% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $2.60B (to Q2 2026). Net income: $275M, trailing twelve months to Q2 2026. Operating margin: 10%, trailing twelve months to Q2 2026. EPS: $1.26, trailing twelve months to Q2 2026.

AVAHAveanna Healthcare Holdings Inc.

Healthcare

$12.24+51% 1Y

$12.24

$6.2252 weeks$14.39

AVAH as reported

Aveanna Healthcare Holdings Inc. reported $2.60B of revenue over the trailing twelve months, +20% on the year before. 11 reported series are charted on this page, each one as filed.

$2.60B

Revenue, trailing twelve months · to Q2 2026 · +20% against the twelve months before

Net income: $275M
Net income · +1381% year on year · trailing twelve months to Q2 2026
Operating margin: 10%
Operating margin · trailing twelve months to Q2 2026
EPS: $1.26
EPS · +1300% year on year · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for AVAH, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$2.60B	+20%	Q2 2026
Net income	$275M	+1381%	Q2 2026
EPS	$1.26	+1300%	Q2 2026
Gross margin	32%	n/a	Q2 2026
Operating margin	10%	n/a	Q2 2026
Net margin	10%	n/a	Q2 2026
ROE	285%	n/a	Q2 2026
ROA	10%	n/a	Q2 2026
ROIC	15%	n/a	Q2 2026
Free cash flow	−$60M	n/a	Q4 2022 · 14 quarters behind
P/E	9.71	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.